The effect of saralasin (1-Sar-8-Ala-Angiotensin II) on blood pressure in patients with cushing's syndrome
- 1 July 1976
- journal article
- Published by Springer Nature in Klinische Wochenschrift
- Vol. 54 (14) , 661-663
- https://doi.org/10.1007/bf01469145
Abstract
Um die Bedeutung des Renin-Angiotensin Systems in der Pathogenese der Hypertonie bei Cushing-Syndrom zu untersuchen, wurden bei 2 Patienten mit Hyperkortizismus 20 mg Saralasin (1-Sar-8-Ala-Angiotensin II) über einen Zeitraum von 30 min unter ständiger Blutdruckkontrolle infundiert. Zusätzlich diente ein Patient mit primärem Aldosteronismus, einer etablierten Form von Mineralokortikoidhochdruck, als Kontrolle.Keywords
This publication has 8 references indexed in Scilit:
- Radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive patientsClinical Pharmacology & Therapeutics, 1975
- Pathogenesis of hypertension in Cushing's syndromeThe American Journal of Medicine, 1975
- RADIOIMMUNOASSAY FOR ALDOSTERONE WITHOUT CHROMATOGRAPHYActa Endocrinologica, 1973
- Plasma renin and the antihypertensive effect of 1-Sar-8-Ala-angiotensin IIEuropean Journal of Pharmacology, 1973
- Measurement of Plasma Renin Substrate by Radioimmunoassay of Angiotensin I: Concentration in Syndromes Associated with Steroid ExcessJournal of Clinical Endocrinology & Metabolism, 1973
- Role of the Pressor Action of Angiotensin IIin Experimental HypertensionCirculation Research, 1971
- Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects1Journal of Clinical Endocrinology & Metabolism, 1969
- Work of Digital Vasoconstriction Produced by Infused Norepinephrine in Cushing's SyndromeJournal of Applied Physiology, 1958